BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1476397)

  • 1. Hyperprolactinemia and lens opacities.
    Costagliola C; Mastropasqua L; Amato G; Carella C
    Ann Ophthalmol; 1992 Nov; 24(11):418-9. PubMed ID: 1476397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 4. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 5. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
    Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
    Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma).
    Hartman N; Voron SC; Hershman JM
    Headache; 1995; 35(7):430-1. PubMed ID: 7672963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia and reproductive disorders--a profile from north east.
    Choudhury SD; Goswami A
    J Assoc Physicians India; 1995 Sep; 43(9):617-8. PubMed ID: 8773064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperprolactinemia in women--a series of 71 cases.
    Seshadri MS; Sud A; Chandy MJ; Thomas J; Kanagasbapathy AS; Cherian AM
    J Assoc Physicians India; 1993 Nov; 41(11):706-7. PubMed ID: 8005922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.
    Merola B; Colao A; Caruso E; Sarnacchiaro F; Briganti F; Lancranjan I; Lombardi G; Schettini G
    Gynecol Endocrinol; 1991 Dec; 5(4):267-76. PubMed ID: 1796748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anejaculation as the presenting feature of pituitary microadenoma.
    Nair S; Milsom S
    Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
    Banerjee A; Wynne K; Tan T; Hatfield EC; Martin NM; Williamson C; Meeran K
    Clin Endocrinol (Oxf); 2009 May; 70(5):812-3. PubMed ID: 18803677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
    López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
    Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
    Mychka VB; Chazova IE; Dmitriev VV; Masenko VP
    Ter Arkh; 2000; 72(9):10-3. PubMed ID: 11076407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prolactin level.
    Piketty ML; Nataf F; Dilouya A; Roux FX
    J Neurosurg; 2000 Feb; 92(2):368-9. PubMed ID: 10659034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperprolactinemia].
    König MP; Kopp P
    Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperprolactinemia. Its relation to galactorrhea, amenorrhea, pituitary tumor and its management.
    Ge QS; Xu L; Wang HL; Gu CX; Lin SQ; Xu YD; Yu KM; Xie YZ; Shi YF; Zang X
    Chin Med J (Engl); 1985 Aug; 98(8):543-50. PubMed ID: 3937678
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.